Central Pathology Review and Tissue MicroArrays. Dr Lisa Storer Children s Brain Tumour Research Centre Nottingham

Similar documents
Use of tissue micro array (TMA) in routine clinical analysis

Inti Zlobec 1*, Viktor H Koelzer 1,2, Heather Dawson 1,2, Aurel Perren 1,2 and Alessandro Lugli 1,2

Workflow. Connecting the Pieces For Total Patient Care

Veridiam Tissue Arrayer

Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies

LN04 - Lymphoma Tissue Microarray

CC01 - Colon Cancer Tissue Microarray

Visual interpretation in pathology

Abstract. Background. Objective

microrna Presented for: Presented by: Date:

FAQs for UK Pathology Departments

ANATOMICAL PATHOLOGY TARIFF

Dako IT S ABOUT TIME. Interpretation Guide. Agilent Pathology Solutions. ALK, ROS1 and RET IQFISH probes (Dako Omnis) MET IQFISH probe (Dako Omnis)

Immune Cell Phenotyping in Solid Tumors using Quantitative Pathology

TRIPath FEE Schedule

PD-L1 Analyte Control DR

Quality Assurance of Ultrasound Imaging in Radiation Therapy. Zuofeng Li, D.Sc. Murty S. Goddu, Ph.D. Washington University St.

MT09 - Normal Human Tissue Microarray, FDA

Quality Assurance and Quality Control in the Pathology Dept.

Quality in Control ALK-Lung Analyte Control (EML4-ALK) ALK-Lymphoma Analyte Control (NPM-ALK)

What in the world is Histotechnology? Karen Stiffler, MA, HTL Program Director for Histotechnology

46. Merkel Cell Carcinoma

NordiQC External Quality Assurance in Immunohistochemistry

Gaining New Insights Through IF Multiplexed Staining and Analysis. Tyna Hope, Ph.D. P.Eng Biomarker Imaging Research Laboratory October 5, 2017

Tissue microarray technology for high-throughput molecular profiling of cancer

Pollen Slide Mounting Protocol

HER2 FISH pharmdx TM Interpretation Guide - Breast Cancer

Layered-IHC (L-IHC): A novel and robust approach to multiplexed immunohistochemistry So many markers and so little tissue

Applications of IHC. Determination of the primary site in metastatic tumors of unknown origin

Version 2 of these Guidelines were drafted in response to published updated ASCO/CAP HER2 test Guideline Recommendations-

IHC Stainer platforms. Overview, pros and cons

G enomics, transcriptomics, and proteomics. Demystified... Tissue microarray technology REVIEW

Optimal algorithm for HER2 testing

4. Monitoring of PAP test with Cervical Biopsy Correlations

Muscle biopsies. There are two different types of muscle biopsy. 1. Needle biopsy

Abstract for Blood Bag Production. This abstract refers to blood bag production considering general and process information

Guideline. Associated Documents ASCO CAP 2018 GUIDELINES and SUPPLEMENTS -

Aspects of quality in breast pathology. Andrew Lee Nottingham University Hospitals

Interpretation Guide. Product Name: ALK Cell Line Analyte Control Product Codes: ALK2/CS and ALK2/CB. Page 1 of 9

Reliability of a Tissue Microarray in Detecting Thyroid Transcription Factor-1 Protein in Lung Carcinomas

Data Mining for Research and Diagnostics

Quality assurance and quality control in pathology in breast disease centers

Clinical Validation of Cytocell Pathology Probes

Reporting of Cancer Stage Information by Acute Care Hospitals in Ontario

Cost Effectiveness of Manual Tissue Microarray Technique in Diagnostic Immunohistochemistry

ab Colon cancer tissue array with progressive changes, 48 cases, 96 samples (1.5mm), set 1

ab Nervous system tumor tissue array, 102 cases (1.5mm)

Utility of Adequate Core Biopsy Samples from Ultrasound Biopsies Needed for Today s Breast Pathology

Is digital pathology ready for use in routine histopathology? Dr David Snead University Hospitals of Coventry and Warwickshire NHS Trust Coventry UK

Welcome. Nanostring Immuno-Oncology Summit. September 21st, FOR RESEARCH USE ONLY. Not for use in diagnostic procedures.

Post Neoadjuvant therapy: issues in interpretation

ab Prostate cancer tissue array, 24 cases, 48 samples (1.5mm)

Abbott Cell-Dyn Reticulocyte Method Comparison and Reticulocyte Normal Reference Range Evaluation

Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Pathology. AGO e. V. in der DGGG e.v. sowie in der DKG e.v.

ONCO TEAM DIAGNOSTIC

COMPUTER-AIDED HER-2/neu EVALUATION IN EXTERNAL QUALITY ASSURANCE (EQA) OF BREAST CANCER SCREENING PROGRAMME

Cancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC

Corporate Medical Policy

Assessment of Breast Cancer with Borderline HER2 Status Using MIP Microarray

HER2 ISH (BRISH or FISH)

Breast Cancer Diagnosis, Treatment and Follow-up

Soft tissue biopsy needles

DeltaCut / CoreCut / PrimoCut

Histopathology National Quality Improvement Programme Data Report 2015 Edition 3 created July 2016

Automatic Probe Assembly Machine

Update on Oral HPV Service and Related Research K Cuschieri, presented at Shine Meeting 25/09/12.

HER2 CISH pharmdx TM Kit Interpretation Guide Breast Cancer

Next-Generation Immunohistochemistry: Multiplex tissue imaging with mass cytometry

ASSEMBLY AUTOMATION FOR PERFECT CANNUL A BONDING

Observership Program Anatomical Pathology

Single Use Curlew TM Multiple Biopsy Forceps

MALDI Imaging Mass Spectrometry

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

SOMAPLEX REVERSE PHASE PROTEIN MICROARRAY HUMAN KIDNEY TUMOR & NORMAL TISSUE

Genetic Analysis of Anxiety Related Behaviors by Gene Chip and In situ Hybridization of the Hippocampus and Amygdala of C57BL/6J and AJ Mice Brains

DeltaCut / PrimoCut. Cannula systems for gentle punch biopsy. Organ biopsy

Glossary of Terms Primary Urethral Cancer

Automatic Extraction of Synoptic Data. George Cernile Artificial Intelligence in Medicine AIM

CONTRACTING ORGANIZATION: Johns Hopkins Bloomberg School of Public Health

Surgical Pathology Lab of the Future. Thomas M. Grogan, M.D. Professor of Pathology, University of Arizona Founder, Ventana Medical Systems, Inc.

Assessment of Microvessel Density (Angiogenesis) And Its Correlation with Tumor Grade

The innovative aspects are that the test automatically generates a report on ALK status that any clinician can interpret.

H&E, IHC anti- Cytokeratin

Human Papillomavirus Testing in Head and Neck Carcinomas

Review Paper Tissue Microarray Technology a Novel research tool for Oral Squamous cell Carcinoma: A Review

Three Hours Thirty Minutes

Breast Cancer Diversity Various Disease Subtypes Clinical Diversity

Cell-free Expression Microarrays

Kidney Summary. Mark Haas Cedars-Sinai Medical Center Los Angeles, California, USA

MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site

Same Day, Cost-Effective Aneuploidy Detection with Agilent Oligonucleotide array CGH and MDA Single Cell Amplification Method

NHS breast screening Helping you decide

Androgen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target?

IT S ABOUT TIME. IQFISH pharmdx Interpretation Guide THREEHOURSTHIRTYMINUTES. HER2 IQFISH pharmdxtm. TOP2A IQFISH pharmdxtm

ab Stomach cancer tissue array of 228 cases (1.1mm)

CYTOLOGY: What every general practitioner should know ( and every future specialist)

Virtual Microscopy: A Tipping Point in Tissue Based Research and Education. James Diamond Peter Hamilton Queen s University of Belfast

Product Introduction. Product Codes: HCL029, HCL030 and HCL031. Issue

Neutrophils contribute to fracture healing by synthesizing fibronectin+ extracellular matrix rapidly after injury

Quality in Control. ROS1 Analyte Control. Product Codes: HCL022, HCL023 and HCL024

Transcription:

Central Pathology Review and Tissue MicroArrays Dr Lisa Storer Children s Brain Tumour Research Centre Nottingham

What is a tissue microarray? Tissue microarrays (TMAs) consist of paraffin blocks in which up to 1000 separate tissue cores are assembled to allow multiplex histological analysis

Why should we use TMAs? Limitations in molecular clinical analysis on FFPE Small patient sample size Limited availability/expense of diagnostic reagents Cumbersome nature of procedures TMAs use novel sampling approach to produce samples of regular size and shape Allow high throughput analysis

Advantages of using TMAs Allow the analysis of many patient samples simultaneously Conservation of precious tissue samples Improved internal experimental control Reduced consumption of antibodies and other reagents Wide applicability to many molecular techniques including RNA and protein expression analysis, IHC, ISH, FISH, in situ PCR Cheaper and easier to perform technique on 1 slide containing 100 samples than 100 separate slides

Disadvantages Need accurate record keeping to prevent misplacing of cores Small cores sampled may not be representative of the whole tumour Particularly true in heterogenous cancers e.g. prostate adenocarcimoma and Hodgkin lymphoma Metastatic Medulloblastoma c ) d e ) highly positive regions Patches of positivity negative regions

Tissue Microarray Procedure A hollow needle used to remove 0.6mm diameter core from region of interest 1.0, 1.5 and 2.0mm diameter punches available Insert core into a recipient paraffin block in a precisely spaced array pattern using co-ordinates Section TMA block on microtome Mount on microscope slide Stain and analyse H&E IHC FISH

Building TMAs a Donor block b c Spotted H&E Recipient block

Importance of Central Pathology Review All cases submitted to a study should under go central pathology review by a pathologist Review of diagnostic slides H&E Any IHC Clinical information Other supporting techniques e.g. EM, FISH Once diagnosis has been confirmed, regions of interest should be spotted onto H&E by pathologist

Important considerations Always perform a central pathology review Spot multiple cores of representative areas label each core e.g. a, b, c Design TMA block before starting procedure Record co-ordinates of cores to enable each core to be tracked back to the original spot on a H&E Always include a reference core to allow orientation of block and sections Don t make your block symmetrical Always leave enough material in the donor block to allow use for further diagnostic testing

Manual Have to line up block and slide Punch core Move co-ordinates of stage for next sample Semi-automated Touch screen for set up of spacing, positioning Automated stage 4 recipient blocks at a time Automated Types of TMAers Automatic record keeping so no misplacing of cores

Automated Tissue Microarrayers I Spot region of interest on donor block with an oil pen Insert donor blocks into tray in order Load blocks into machine Pen marking is recognised by camera Puncher acquires sample and moves it to recipient block

Automated Tissue Microarrayers II Scan donor block and corresponding H&E Overlay images and mark on donor block image where to core Scan block and produce image on screen Mark on donor block image where to take core from Back fill donor block with paraffin to prevent collapse of small blocks

Case Study Nottingham have consented 2 families for PM examination, collection and storage of tissue for CCLG registration Both had been receiving treatment at NUH Both CCLG consented whilst alive: biopsy, debulk and bloods CCLG registered Performed limited PM for specific tissue collection Dependent on clinicians relationship with family Family must sign CCLG PM consent form as well as hospital PM consent form Consent received from the living does not cover the deceased